TargetMol

JOSAMYCIN

Product Code:
 
TAR-T7148
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7148-25mg25mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7148-1mL1 mL * 10 mM (in DMSO)£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7148-50mg50mg£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7148-100mg100mg£164.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7148-500mg500mg£298.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Bioactivity:
JOSAMYCIN is a macrolide antibiotic exhibiting antimicrobial activity. The dissociation constant Kd from ribosome for Josamycin is 5.5 nM.
CAS:
16846-24-5
Formula:
C42H69NO15
Molecular Weight:
828.006
Pathway:
Microbiology/Virology
Purity:
0.9138
SMILES:
[H][C@@]1(C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1)O[C@@H]1[C@@H](C)O[C@@H](O[C@@]2([H])[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@@H]2OC)[C@H](O)[C@H]1N(C)C
Target:
Antibacterial; Antibiotic

References

Auzou M , Caillon J , Poyart C , et al. In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract infections in France[J]. Médecine et Maladies Infectieuses, 2015, 45(7):293-296. Katsuhiko M , Kanta T , Kei O , et al. Topical Application of Josamycin Inhibits Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice[J]. Journal of Pharmacy & Pharmaceutical Sciences, 2017, 20:38-. Eun-Young C , So-Hui C , Jin-Yi H , et al. Josamycin suppresses, Prevotella intermedia, lipopolysaccharide-induced production of nitric oxide and interleukin-1? in murine macrophages[J]. Biomedicine & Pharmacotherapy, 2018, 105:498-505.